Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free ATAI Stock Alerts

Atai Beckley (ATAI) Financials

Atai Beckley logo
$7.15 +1.79 (+33.40%)
Closing price 04:00 PM Eastern
Extended Trading
$7.08 -0.07 (-0.91%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Atai Beckley

Annual Income Statements for Atai Beckley

This table shows Atai Beckley's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 3.72 4.03 -1.41 124 -18 -14 -5.28 -6.94 -4.74 -4.95 -6.87
Consolidated Net Income / (Loss)		 3.72 4.03 -1.45 124 -19 -15 -5.71 -7.05 -4.75 -4.95 -6.87
Net Income / (Loss) Continuing Operations		 3.72 4.03 -8.69 -9.91 -19 -15 -5.71 -7.05 -4.75 -4.95 -6.87
Total Pre-Tax Income 		5.26 6.95 -8.47 -9.91 -20 -17 -5.96 -7.90 -5.71 -5.82 -7.38
Total Operating Income		 5.12 7.99 -8.27 -9.87 -17 -17 -10 -8.20 -5.84 -5.90 -9.17
Total Gross Profit		 29 32 0.64 -0.42 5.15 9.79 16 15 16 19 19
Total Revenue		 56 64 1.29 0.19 14 25 32 30 31 37 38
Operating Revenue		 56 64 1.29 0.19 14 25 32 30 31 37 38
Total Cost of Revenue		 28 32 0.64 0.62 8.89 15 15 15 15 17 20
Operating Cost of Revenue		 28 32 0.64 0.62 8.89 15 15 15 15 17 20
Total Operating Expenses		 24 24 8.91 9.44 22 26 27 23 22 25 28
Selling, General & Admin Expense		 10 12 5.25 6.33 12 15 15 11 10 11 11
Marketing Expense		 7.28 6.59 0.76 0.81 4.90 8.23 10 11 11 14 12
Research & Development Expense		 5.94 5.64 2.90 2.85 1.70 1.36 1.85 0.98 0.65 0.51 0.44
Other Operating Expenses / (Income)		 -0.20 -0.02 0.00 -0.55 2.42 0.86 -0.00 -0.00 -0.00 -0.02 -0.57
Impairment Charge		 0.05 - - 0.00 1.28 0.48 - - 0.00 0.00 4.85
Total Other Income / (Expense), net		 0.14 -1.04 -0.21 -0.04 -3.37 -0.52 4.46 0.30 0.14 0.07 1.79
Interest & Investment Income		 0.31 -0.81 -0.20 -0.58 -3.38 -0.09 0.17 0.11 0.14 0.14 0.09
Other Income / (Expense), net		 -0.17 -0.23 -0.01 0.54 0.01 -0.43 4.29 0.19 -0.00 -0.06 1.70
Income Tax Expense		 1.54 2.92 0.22 0.00 -1.03 -1.58 -0.24 -0.86 -0.96 -0.88 -0.51
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 -0.04 -0.63 -1.00 -1.29 -0.43 -0.10 -0.01 -0.00 -0.00
Basic Earnings per Share		 $0.49 $0.57 ($0.21) $18.25 ($2.52) ($1.57) ($0.57) ($0.11) ($0.08) ($0.08) ($0.11)
Weighted Average Basic Shares Outstanding		 45.91M 45.85M 48.48M 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M
Diluted Earnings per Share		 $0.49 $0.57 ($0.21) $18.25 ($2.52) ($1.57) ($0.57) ($0.11) ($0.08) ($0.08) ($0.11)
Weighted Average Diluted Shares Outstanding		 45.91M 45.85M 48.48M 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M
Weighted Average Basic & Diluted Shares Outstanding		 45.91M 45.85M 48.48M 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M

Quarterly Income Statements for Atai Beckley

This table shows Atai Beckley's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -33 -33 44 -18 -27 -57 -26 -39 -26 -28 -61
Consolidated Net Income / (Loss)		 -34 -34 43 -19 -27 -57 -26 -39 -26 -28 -61
Net Income / (Loss) Continuing Operations		 -34 -34 43 -19 -27 -57 -26 -39 -26 -28 -61
Total Pre-Tax Income 		-33 -32 44 -18 -26 -57 -26 -39 -26 -28 -61
Total Operating Income		 -33 -32 -27 -34 -24 -26 -23 -30 -20 -25 -28
Total Gross Profit		 0.04 0.17 0.09 0.02 0.00 0.27 0.04 -0.01 1.56 0.72 0.75
Total Revenue		 0.04 0.17 0.09 0.02 0.00 0.27 0.04 -0.01 1.56 0.72 0.75
Operating Revenue		 0.04 0.17 0.09 0.02 0.00 0.27 0.04 -0.01 1.56 0.72 0.75
Total Cost of Revenue		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses		 33 32 27 34 24 26 23 30 22 26 29
Selling, General & Admin Expense		 14 17 14 19 13 13 10 11 11 15 15
Research & Development Expense		 19 15 13 14 12 13 12 19 11 11 15
Total Other Income / (Expense), net		 0.06 0.20 71 15 -1.60 -31 -3.86 -8.91 -5.73 -2.38 -33
Interest Expense		 0.62 0.66 0.69 0.69 0.69 0.70 0.78 0.95 0.90 1.58 0.00
Interest & Investment Income		 0.28 0.30 0.61 0.72 0.31 0.12 0.16 0.19 0.19 4.04 0.50
Other Income / (Expense), net		 0.41 0.56 71 15 -1.22 -31 -3.24 -8.15 -5.01 -4.84 -33
Income Tax Expense		 0.17 0.19 0.24 0.43 -0.00 0.02 -0.18 -0.19 0.16 0.09 0.13
Other Gains / (Losses), net		 -1.03 -1.93 -0.24 -0.39 -1.70 -0.27 -0.03 - 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 -1.22 -0.73 -0.87 -0.85 -0.67 -0.06 -0.03 -0.03 -0.03 -0.02 -0.02
Basic Earnings per Share		 ($0.21) ($0.21) $0.28 ($0.11) ($0.17) ($0.36) ($0.16) ($0.24) ($0.15) ($0.14) ($0.28)
Weighted Average Basic Shares Outstanding		 155.79M 155.79M 155.79M 158.83M 158.89M 160.39M 160.62M 160.16M 176.27M 196.56M 217.60M
Diluted Earnings per Share		 ($0.21) ($0.21) $0.25 ($0.08) ($0.17) ($0.36) ($0.16) ($0.24) ($0.15) ($0.14) ($0.28)
Weighted Average Diluted Shares Outstanding		 155.79M 155.79M 177.57M 158.83M 158.89M 160.39M 160.62M 160.16M 176.27M 196.56M 217.60M
Weighted Average Basic & Diluted Shares Outstanding		 166.01M 166.01M 166.01M 166.03M 167.41M 167.80M 167.80M 198.31M 200.34M 214.34M 363.19M

Annual Cash Flow Statements for Atai Beckley

This table details how cash moves in and out of Atai Beckley's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -12 1.14 0.70 -9.53 -5.22 -6.38 -6.49 -2.37 0.73 -3.24 6.97
Net Cash From Operating Activities		 7.39 9.97 8.96 -46 -8.31 -4.29 -5.00 -2.12 1.23 -0.46 -2.26
Net Cash From Continuing Operating Activities		 7.39 9.97 8.96 -46 -8.31 -4.29 -5.00 -2.12 1.23 -0.46 -2.27
Net Income / (Loss) Continuing Operations		 3.72 4.03 -1.45 124 -19 -15 -5.71 -7.05 -4.75 -4.95 -6.87
Consolidated Net Income / (Loss)		 3.72 4.03 -1.45 124 -19 -15 -5.71 -7.05 -4.75 -4.95 -6.87
Depreciation Expense		 1.22 1.33 1.50 1.94 2.52 4.60 3.61 3.28 3.10 3.32 3.07
Non-Cash Adjustments To Reconcile Net Income		 1.85 3.06 7.79 -160 7.62 2.37 -4.12 0.02 0.43 0.44 3.47
Changes in Operating Assets and Liabilities, net		 0.60 1.55 1.12 -11 0.11 4.21 1.23 1.63 2.45 0.73 -1.95
Net Cash From Investing Activities		 -8.50 -5.69 -14 175 -5.30 -2.94 -1.57 -0.36 -0.56 -2.78 6.96
Net Cash From Continuing Investing Activities		 -8.50 -5.69 -14 175 -5.30 -2.94 -1.57 -0.36 -0.56 -2.78 6.96
Purchase of Property, Plant & Equipment		 -2.39 -0.48 -0.47 -1.03 -0.18 -0.76 -0.70 -0.23 -0.32 -2.74 -0.18
Acquisitions		 0.00 0.00 -0.92 0.00 -4.96 -2.26 -0.75 -0.10 -0.25 -0.03 0.00
Sale of Property, Plant & Equipment		 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.01
Other Investing Activities, net		 0.00 -1.55 0.00 -1.78 - 0.08 -0.13 -0.02 0.00 -0.01 7.14
Net Cash From Financing Activities		 -10 -3.14 5.42 -138 8.27 0.97 0.13 0.03 0.06 -0.01 2.34
Net Cash From Continuing Financing Activities		 -10 -3.14 5.42 -138 8.27 0.97 0.13 0.03 0.06 -0.01 2.34
Repayment of Debt		 - 0.00 0.00 -2.62 -1.29 -2.74 -0.31 - 0.00 0.00 -3.01
Issuance of Debt		 0.00 0.00 0.50 2.18 0.00 3.02 0.43 - 0.00 0.00 5.30
Issuance of Common Equity		 0.00 0.00 4.95 0.00 9.58 1.31 0.04 0.03 0.07 - 0.05
Other Financing Activities, net		 0.49 -0.12 -0.03 -0.04 -0.02 -0.01 -0.02 -0.00 -0.01 -0.01 -0.01
Effect of Exchange Rate Changes		 -0.17 -0.00 -0.01 -0.69 0.12 -0.13 -0.05 0.08 -0.00 0.01 -0.07
Cash Interest Paid		 0.00 0.00 0.01 0.04 0.03 0.03 0.00 - 0.00 0.00 0.06
Cash Income Taxes Paid		 3.72 3.71 3.03 34 0.03 0.02 0.02 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Atai Beckley

This table details how cash moves in and out of Atai Beckley's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Change in Cash & Equivalents		 -4.73 -45 -65 -31 -11 0.47 11 -17 31 3.65 -32
Net Cash From Operating Activities		 -21 -23 -18 -22 -23 -16 -19 -24 -18 -14 -23
Net Cash From Continuing Operating Activities		 -21 -23 -18 -22 -23 -16 -19 -24 -18 -14 -23
Net Income / (Loss) Continuing Operations		 -34 -34 43 -19 -27 -57 -26 -39 -26 -28 -61
Consolidated Net Income / (Loss)		 -34 -34 43 -19 -27 -57 -26 -39 -26 -28 -61
Depreciation Expense		 0.07 0.08 0.07 0.10 0.08 0.08 0.08 0.23 0.22 0.23 0.23
Non-Cash Adjustments To Reconcile Net Income		 11 11 8.49 8.52 7.81 7.33 6.48 2.70 4.13 -1.90 5.92
Changes in Operating Assets and Liabilities, net		 2.47 0.42 -70 -12 -3.19 34 0.28 12 4.13 15 32
Net Cash From Investing Activities		 16 -22 -46 -0.82 11 16 25 6.56 -11 9.78 -68
Net Cash From Continuing Investing Activities		 16 -22 -46 -0.82 11 16 25 6.56 -11 9.78 -68
Purchase of Property, Plant & Equipment		 -0.44 -0.13 -0.00 -0.02 -0.01 - -0.00 -0.01 -0.27 -0.13 -0.40
Acquisitions		 - - - - 0.00 - - - -5.75 - -7.22
Purchase of Investments		 -3.00 -40 -137 -8.72 -31 -66 87 -5.00 -5.00 -5.00 -39
Sale and/or Maturity of Investments		 19 18 94 8.62 44 85 -58 11 0.00 15 -11
Other Investing Activities, net		 0.00 - -2.70 -0.71 -1.00 -2.92 -3.83 - 0.00 - -10
Net Cash From Financing Activities		 0.21 -0.10 - -8.46 0.00 0.33 4.89 0.15 60 7.76 60
Net Cash From Continuing Financing Activities		 0.21 -0.10 - -8.46 0.00 0.33 4.89 0.15 60 7.76 60
Issuance of Common Equity		 - - - - 0.00 - - - 60 30 50
Other Financing Activities, net		 0.21 - - -8.48 0.00 0.33 0.06 0.15 -0.17 -0.37 1.93
Effect of Exchange Rate Changes		 0.16 -0.08 0.32 -0.21 -0.06 0.07 0.24 0.12 0.03 0.21 -0.47
Cash Income Taxes Paid		 - - 0.07 - 0.00 - -0.75 0.04 0.10 0.10 -0.08

Annual Balance Sheets for Atai Beckley

This table presents Atai Beckley's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 73 73 87 49 97 89 80 69 63 63 58
Total Current Assets		 50 49 56 31 26 19 12 9.46 9.92 9.13 16
Cash & Equivalents		 39 38 8.21 28 22 17 11 7.97 8.47 5.00 12
Accounts Receivable		 7.76 9.36 0.01 0.06 0.03 0.35 0.15 0.85 0.31 0.37 0.04
Prepaid Expenses		 3.95 1.28 0.50 1.14 2.37 0.92 0.49 0.64 1.13 3.75 3.69
Plant, Property, & Equipment, net		 10 8.84 6.49 5.45 6.04 5.86 5.73 4.75 4.26 5.30 4.60
Total Noncurrent Assets		 13 15 24 12 65 64 62 55 49 48 38
Long-Term Investments		 5.76 7.83 11 9.66 6.57 6.77 5.96 5.51 5.35 5.21 0.00
Goodwill		 5.00 4.79 - 0.00 29 30 31 28 28 27 23
Intangible Assets		 0.15 0.12 0.88 2.49 19 17 15 11 8.29 6.34 4.64
Other Noncurrent Operating Assets		 1.92 1.64 0.61 0.12 8.21 9.96 11 9.57 7.76 9.74 10.00
Total Liabilities & Shareholders' Equity		 73 73 87 49 97 89 80 69 63 63 58
Total Liabilities		 13 12 26 2.87 47 50 50 48 47 52 54
Total Current Liabilities		 12 11 22 2.87 38 42 42 42 44 49 49
Short-Term Debt		 - 0.00 - 0.00 0.72 1.05 - - - 0.00 0.14
Accrued Expenses		 8.77 8.92 4.30 2.64 6.86 7.23 7.56 8.11 6.92 7.72 8.08
Current Deferred Revenue		 3.50 2.57 0.31 0.24 25 31 32 32 36 38 39
Other Current Liabilities		 - - - 0.00 5.77 3.32 2.72 2.45 1.85 2.48 2.19
Total Noncurrent Liabilities		 0.28 0.29 3.88 0.00 8.72 8.15 7.58 5.57 3.04 3.12 4.54
Long-Term Debt		 - - - - - - - - - 0.00 2.15
Noncurrent Deferred & Payable Income Tax Liabilities		 - 0.00 - 0.00 6.93 4.46 3.91 2.74 1.70 0.78 0.30
Other Noncurrent Operating Liabilities		 - - - 0.00 1.79 3.69 3.67 2.83 1.34 2.35 2.09
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 61 61 56 40 44 31 30 21 16 11 4.57
Total Preferred & Common Equity		 61 61 56 40 43 31 29 21 16 11 4.58
Total Common Equity		 61 61 56 40 43 31 29 21 16 11 4.58
Common Stock		 63 62 60 60 81 84 86 79 77 76 79
Retained Earnings		 3.50 7.38 3.97 -10 -29 -46 -49 -52 -55 -59 -68
Treasury Stock		 -1.32 -4.29 -4.26 -4.04 -3.98 -1.79 -1.54 -1.25 -1.16 -1.12 -1.17
Accumulated Other Comprehensive Income / (Loss)		 -4.38 -3.89 -4.12 -5.57 -5.38 -5.76 -5.89 -5.36 -5.21 -5.06 -5.35
Noncontrolling Interest		 - 0.00 0.05 0.05 0.79 0.13 0.49 0.06 -0.01 -0.01 -0.01

Quarterly Balance Sheets for Atai Beckley

This table presents Atai Beckley's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 343 281 254 308 269 216 198 196 189 240
Total Current Assets		 317 268 243 216 118 118 114 116 103 131
Cash & Equivalents		 143 186 141 76 19 19 30 48 62 30
Restricted Cash		 - - - - 5.00 15 15 10 0.00 0.00
Short-Term Investments		 162 64 86 133 87 69 56 50 34 84
Note & Lease Receivable		 0.00 8.85 9.02 - 0.52 1.90 5.70 - - 10
Prepaid Expenses		 13 9.20 6.26 6.83 5.73 4.69 7.45 7.77 6.74 5.90
Plant, Property, & Equipment, net		 0.73 1.11 1.04 0.99 0.92 0.87 0.87 2.68 2.90 3.01
Total Noncurrent Assets		 24 12 9.78 91 151 97 83 77 84 106
Long-Term Investments		 8.50 5.85 3.99 3.66 43 32 34 42 54 54
Goodwill		 - - - - - - - 0.33 0.33 0.33
Intangible Assets		 - - - - - - - 3.16 3.12 3.03
Other Noncurrent Operating Assets		 8.74 4.67 4.63 76 94 65 49 32 26 49
Total Liabilities & Shareholders' Equity		 343 281 254 308 269 216 198 196 189 240
Total Liabilities		 47 40 38 40 46 47 51 44 45 80
Total Current Liabilities		 26 20 18 20 15 18 20 29 26 17
Short-Term Debt		 0.00 0.00 - - 0.24 0.24 0.26 12 0.44 0.53
Accounts Payable		 3.51 4.92 3.86 5.51 3.84 3.81 4.88 2.71 4.04 5.37
Accrued Expenses		 22 14 13 13 11 13 12 8.68 15 10
Other Current Liabilities		 0.26 1.22 1.21 1.18 - 0.68 2.55 5.46 6.56 0.18
Total Noncurrent Liabilities		 21 20 20 20 31 30 32 15 20 63
Long-Term Debt		 15 15 15 15 15 15 20 9.30 0.00 0.00
Other Noncurrent Operating Liabilities		 5.60 5.34 5.16 5.06 16 14 11 5.71 20 63
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 296 241 216 269 223 169 146 152 144 160
Total Preferred & Common Equity		 289 237 213 266 223 168 146 152 144 160
Total Common Equity		 289 237 213 266 223 168 146 152 144 160
Common Stock		 780 801 810 818 819 822 827 898 919 996
Retained Earnings		 -465 -544 -577 -533 -578 -635 -661 -727 -754 -815
Accumulated Other Comprehensive Income / (Loss)		 -26 -21 -21 -19 -19 -19 -20 -19 -21 -21
Noncontrolling Interest		 6.68 3.82 3.09 2.24 0.71 0.64 0.60 0.22 0.19 0.16

Annual Metrics And Ratios for Atai Beckley

This table displays calculated financial ratios and metrics derived from Atai Beckley's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 45,905,582.00 45,854,348.00 48,482,724.00 47,592,384.00 63,459,214.00 63,304,090.00 63,247,176.00 63,244,340.00 64,000,260.00 63,995,782.00 63,912,442.00
DEI Adjusted Shares Outstanding		 45,905,582.00 45,854,348.00 48,482,724.00 47,592,384.00 63,459,214.00 63,304,090.00 63,247,176.00 63,244,340.00 64,000,260.00 63,995,782.00 63,912,442.00
DEI Earnings Per Adjusted Shares Outstanding		 0.08 0.09 -0.03 2.61 -0.28 -0.22 -0.08 -0.11 -0.07 -0.08 -0.11
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 3.62 4.63 -5.79 -6.91 -12 -12 -7.29 -5.74 -4.09 -4.13 -6.42
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -27.60% -25.71% -37.83% -93.47%
Earnings before Interest and Taxes (EBIT)		 4.95 7.76 -8.28 -9.33 -17 -17 -6.13 -8.01 -5.85 -5.96 -7.47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 6.17 9.09 -6.78 -7.39 -14 -12 -2.52 -4.74 -2.75 -2.64 -4.40
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.96 6.14 5.14 -12 -26 -4.28 -5.05 -0.27 1.15 -2.74 -0.39
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 16 15 3.89 8.50 22 15 13 7.33 2.09 0.70 -5.32
Increase / (Decrease) in Invested Capital		 0.66 -1.51 -11 4.62 14 -7.29 -2.25 -5.47 -5.24 -1.38 -6.02
Book Value per Share		 $1.32 $1.33 $1.22 $0.83 $0.91 $0.48 $0.47 $0.33 $0.25 $0.17 $0.07
Tangible Book Value per Share		 $1.21 $1.22 $1.20 $0.78 ($0.11) ($0.26) ($0.25) ($0.30) ($0.32) ($0.35) ($0.36)
Total Capital		 61 61 62 46 51 39 30 21 16 11 6.87
Total Debt		 0.00 0.00 0.00 0.00 0.72 1.05 0.00 0.00 0.00 0.00 2.29
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.15
Net Debt		 -44 -46 -19 -37 -28 -23 -17 -13 -14 -10 -9.90
Capital Expenditures (CapEx)		 2.39 0.47 0.47 1.03 0.18 0.75 0.70 0.23 0.31 2.74 0.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.56 -0.85 26 0.45 -33 -40 -41 -41 -43 -44 -45
Debt-free Net Working Capital (DFNWC)		 38 37 35 28 -11 -23 -30 -33 -34 -39 -33
Net Working Capital (NWC)		 38 37 35 28 -12 -24 -30 -33 -34 -39 -33
Net Nonoperating Expense (NNE)		 -0.10 0.61 -4.34 -131 6.72 3.90 -1.58 1.30 0.66 0.82 0.45
Net Nonoperating Obligations (NNO)		 -44 -46 -58 -37 -28 -23 -17 -13 -14 -10 -9.90
Total Depreciation and Amortization (D&A)		 1.22 1.33 1.50 1.94 2.52 4.60 3.61 3.28 3.10 3.32 3.07
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.08 $0.09 $0.00 $2.65 ($0.36) ($0.24) ($0.09) ($0.76) ($0.54) ($0.08) ($0.11)
Adjusted Weighted Average Basic Shares Outstanding		 45.91M 45.85M 0.00 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M
Adjusted Diluted Earnings per Share		 $0.08 $0.09 $0.00 $2.65 ($0.36) ($0.24) ($0.09) ($0.76) ($0.54) ($0.08) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding		 45.91M 45.85M 0.00 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $2.65 ($0.36) ($0.24) ($0.09) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 45.91M 45.85M 0.00 47.59M 63.46M 63.30M 63.25M 63.24M 64.00M 64.00M 63.91M
Normalized Net Operating Profit after Tax (NOPAT)		 3.65 4.63 -5.79 -6.91 -11 -11 -7.29 -5.74 -4.09 -4.13 -3.02
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Atai Beckley

This table displays calculated financial ratios and metrics derived from Atai Beckley's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 1.18% 262.50% -53.85% -100.00% 58.72% -54.02% -127.78% 0.00% 163.37% 1,772.50%
EBITDA Growth		 -2.20% -0.47% 232.64% 54.41% 23.09% -80.88% -158.12% -109.48% 0.41% 46.97% -139.74%
EBIT Growth		 -2.47% -0.96% 231.98% 54.12% 22.88% -80.47% -158.83% -109.45% -0.32% 46.69% -138.66%
NOPAT Growth		 0.68% 9.88% 0.77% 10.66% 27.49% 19.25% 40.72% 9.79% 15.42% 1.77% -25.81%
Net Income Growth		 8.53% 9.97% 221.48% 58.97% 20.31% -69.88% -160.67% -103.70% 3.33% 51.64% -132.21%
EPS Growth		 12.50% 12.50% 213.64% 71.43% 19.05% -71.43% -164.00% -200.00% 11.76% 61.11% -75.00%
Operating Cash Flow Growth		 11.99% -3.11% 34.28% 28.01% -6.93% 28.24% -4.94% -10.62% 20.96% 13.15% -20.27%
Free Cash Flow Firm Growth		 0.56% 28.67% -250.49% -299.36% -340.95% -186.67% 123.13% 147.06% 146.65% 153.69% -11.33%
Invested Capital Growth		 -82.14% 54.30% 4,904.27% 8,535.78% 27,795.10% 5,036.71% -54.68% -77.66% -72.93% -111.45% -125.28%
Revenue Q/Q Growth		 -5.13% 364.86% -49.42% -79.31% -100.00% 0.00% -85.35% -112.50% 31,200.00% -53.76% 4.17%
EBITDA Q/Q Growth		 17.94% 4.68% 241.63% -141.15% -38.43% -124.18% 54.49% -48.33% 34.18% -19.35% -105.75%
EBIT Q/Q Growth		 17.95% 4.59% 240.31% -141.77% -37.91% -123.28% 54.26% -48.70% 33.94% -18.64% -104.79%
NOPAT Q/Q Growth		 11.58% 4.07% -19.66% 11.97% 28.24% -6.83% 12.15% -33.95% 32.72% -24.07% -12.52%
Net Income Q/Q Growth		 26.36% 1.70% 228.43% -144.13% -43.03% -109.54% 54.14% -48.19% 32.13% -4.84% -120.20%
EPS Q/Q Growth		 25.00% 0.00% 219.05% -132.00% -112.50% -111.76% 55.56% -50.00% 37.50% 6.67% -100.00%
Operating Cash Flow Q/Q Growth		 30.80% -7.12% 18.50% -19.16% -2.78% 28.11% -19.18% -25.61% 26.57% 21.00% -65.04%
Free Cash Flow Firm Q/Q Growth		 26.65% -1.53% -321.80% -27.14% 19.01% 33.99% 134.04% 158.64% -19.72% -24.03% -43.78%
Invested Capital Q/Q Growth		 -125.52% -219.61% 7,340.80% 46.22% -18.15% -43.03% -33.52% -27.94% -0.80% -124.09% -46.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 0.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -88,275.68% -18,100.58% 50,682.76% -100,811.11% 0.00% -20,627.47% -64,065.00% 0.00% -1,608.87% -4,152.99% -8,202.54%
Operating Margin		 -89,767.57% -18,524.42% -30,843.68% -186,450.00% 0.00% -9,424.54% -56,505.00% 0.00% -1,309.97% -3,515.02% -3,796.53%
EBIT Margin		 -88,672.97% -18,199.42% 50,483.91% -101,922.22% 0.00% -20,693.41% -64,600.00% 0.00% -1,632.35% -4,188.32% -8,233.64%
Profit (Net Income) Margin		 -92,848.65% -19,634.30% 49,851.72% -106,338.89% 0.00% -21,014.29% -65,777.50% 0.00% -1,701.93% -3,858.97% -8,157.28%
Tax Burden Percent		 103.61% 106.67% 98.91% 104.49% 106.61% 100.51% 99.43% 99.51% 100.59% 100.34% 100.21%
Interest Burden Percent		 101.06% 101.13% 99.83% 99.85% 101.50% 101.03% 102.41% 101.98% 103.65% 91.83% 98.86%
Effective Tax Rate		 0.00% 0.00% 0.54% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -296.41% -782.53% 0.00% -105.44% -254.44% 0.00% -31.73% -265.77% -668.85%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -324.70% -784.67% 0.00% -82.07% -247.71% 0.00% -22.61% -258.32% -639.66%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 284.82% 623.55% 0.00% 71.96% 186.26% 0.00% 16.13% 222.97% 589.57%
Return on Equity (ROE)		 -51.84% -56.17% -11.59% -158.98% 0.00% -33.47% -68.18% 0.00% -15.60% -42.80% -79.29%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -230.07% -363.13% -196.46% -261.81% -68.92% 13.47% -13.89% 0.00% 0.00%
Operating Return on Assets (OROA)		 -72.06% -16.43% 51.97% -106.87% 0.00% -33.33% -84.56% 0.00% -13.08% -47.76% -113.64%
Return on Assets (ROA)		 -75.46% -17.73% 51.32% -111.50% 0.00% -33.85% -86.10% 0.00% -13.64% -44.00% -112.58%
Return on Common Equity (ROCE)		 -50.78% -54.96% -11.40% -156.99% 0.00% -33.15% -67.71% 0.00% -15.56% -42.69% -79.09%
Return on Equity Simple (ROE_SIMPLE)		 -65.12% -70.80% -26.82% 0.00% -16.59% -36.05% -89.35% 0.00% -98.08% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -23 -22 -27 -23 -17 -18 -16 -21 -14 -18 -20
NOPAT Margin		 -62,837.30% -12,967.09% -30,676.26% -130,515.00% 0.00% -6,597.18% -39,553.50% 0.00% -916.98% -2,460.51% -2,657.57%
Net Nonoperating Expense Percent (NNEP)		 -3.73% -4.26% 28.29% 2.15% -5.54% -23.37% -6.73% -15.20% -9.11% -7.46% -29.19%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -9.05% -7.06% - - -15.41% -8.23% -12.25% -12.41%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 37,756.76% 9,626.74% 15,667.82% 107,905.56% 0.00% 4,907.33% 25,662.50% 0.00% 681.48% 2,072.32% 1,936.58%
R&D to Revenue		 52,110.81% 8,997.67% 15,275.86% 78,644.44% 0.00% 4,617.22% 30,942.50% 0.00% 728.49% 1,542.70% 1,959.95%
Operating Expenses to Revenue		 89,867.57% 18,624.42% 30,943.68% 186,550.00% 0.00% 9,524.54% 56,605.00% 0.00% 1,409.97% 3,615.02% 3,896.53%
Earnings before Interest and Taxes (EBIT)		 -33 -31 44 -18 -25 -56 -26 -38 -25 -30 -62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -33 -31 44 -18 -25 -56 -26 -38 -25 -30 -61
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.27 1.34 0.80 0.96 1.47 1.33 1.34 1.92 1.77 3.05 7.10
Price to Tangible Book Value (P/TBV)		 1.27 1.34 0.80 0.97 1.47 1.33 1.34 1.98 1.82 3.13 7.25
Price to Revenue (P/Rev)		 1,112.89 1,049.77 639.26 745.46 1,180.77 589.02 588.06 724.60 144.76 190.01 375.70
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.26 0.91 2.23 2.13 2.52 5.62 6.13 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 234.62 264.74 55.80 301.45 683.30 272.60 244.78 422.11 75.46 125.37 320.07
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.24 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.06 0.07 0.06 0.06 0.07 0.09 0.14 0.18 0.14 0.00 0.00
Long-Term Debt to Equity		 0.06 0.07 0.06 0.06 0.07 0.09 0.14 0.12 0.06 0.00 0.00
Financial Leverage		 -1.00 -1.01 -0.88 -0.79 -0.82 -0.88 -0.75 -0.65 -0.71 -0.86 -0.92
Leverage Ratio		 1.12 1.12 1.15 1.17 1.19 1.22 1.22 1.25 1.24 1.30 1.43
Compound Leverage Factor		 1.13 1.14 1.15 1.17 1.20 1.23 1.25 1.28 1.28 1.19 1.41
Debt to Total Capital		 5.79% 6.45% 5.28% 5.90% 6.51% 8.41% 12.34% 15.26% 12.10% 0.30% 0.33%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.11% 0.10% 0.13% 0.15% 4.98% 6.73% 0.30% 0.33%
Long-Term Debt to Total Capital		 5.79% 6.45% 5.28% 5.80% 6.41% 8.28% 12.18% 10.28% 5.37% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.49% 1.34% 0.79% 0.52% 0.30% 0.35% 0.36% 0.19% 0.13% 0.13% 0.10%
Common Equity to Total Capital		 92.72% 92.21% 93.94% 93.58% 93.19% 91.24% 87.31% 84.56% 87.78% 99.57% 99.57%
Debt to EBITDA		 -0.11 -0.11 -0.25 -0.40 -0.51 -0.28 -0.17 -0.14 -0.14 0.00 0.00
Net Debt to EBITDA		 1.76 1.58 3.32 3.72 4.57 2.21 0.92 0.64 0.89 1.26 1.09
Long-Term Debt to EBITDA		 -0.11 -0.11 -0.25 -0.40 -0.50 -0.28 -0.16 -0.10 -0.06 0.00 0.00
Debt to NOPAT		 -0.15 -0.15 -0.17 -0.17 -0.19 -0.20 -0.28 -0.29 -0.30 -0.01 -0.01
Net Debt to NOPAT		 2.38 2.19 2.18 1.60 1.70 1.56 1.54 1.30 1.87 2.17 2.30
Long-Term Debt to NOPAT		 -0.15 -0.15 -0.17 -0.17 -0.19 -0.20 -0.27 -0.20 -0.13 0.00 0.00
Altman Z-Score		 2.46 1.99 2.05 0.70 1.42 -1.60 -2.26 -3.40 -1.36 0.21 3.49
Noncontrolling Interest Sharing Ratio		 2.04% 2.15% 1.58% 1.25% 0.00% 0.97% 0.68% 0.00% 0.25% 0.27% 0.25%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 13.43 13.54 10.96 9.22 7.83 6.68 5.81 3.21 4.07 4.02 7.90
Quick Ratio		 12.97 13.19 10.61 7.69 7.11 5.11 4.66 2.50 3.45 3.76 7.54
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -23 -23 -99 -126 -102 -67 23 59 48 36 20
Operating Cash Flow to CapEx		 -4,765.46% -17,667.19% -921,550.00% -129,188.24% -451,460.00% 0.00% -1,934,100.00% -404,916.67% -6,657.09% -11,097.64% -5,873.99%
Free Cash Flow to Firm to Interest Expense		 -37.16 -35.66 -144.28 -182.37 -148.34 -95.83 29.24 62.21 52.83 22.85 0.00
Operating Cash Flow to Interest Expense		 -33.94 -34.37 -26.87 -31.83 -32.86 -23.12 -24.70 -25.52 -19.82 -8.91 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -34.65 -34.56 -26.87 -31.85 -32.86 -23.12 -24.70 -25.53 -20.12 -8.99 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.42 0.40 0.39 0.33 0.27 0.39 0.36 0.18 1.03 1.22 1.56
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.31 -0.98 71 104 85 48 32 23 23 -5.53 -8.11
Invested Capital Turnover		 -1.14 -0.17 0.01 0.01 0.01 0.02 0.01 0.00 0.03 0.11 0.25
Increase / (Decrease) in Invested Capital		 -0.14 1.16 72 102 85 49 -39 -80 -62 -54 -40
Enterprise Value (EV)		 63 72 19 95 189 103 81 130 141 289 966
Market Capitalization		 300 286 214 234 327 223 195 223 270 439 1,134
Book Value per Share		 $1.43 $1.28 $1.60 $1.46 $1.34 $1.00 $0.87 $0.69 $0.77 $0.72 $0.75
Tangible Book Value per Share		 $1.43 $1.28 $1.60 $1.45 $1.34 $1.00 $0.87 $0.67 $0.75 $0.70 $0.73
Total Capital		 255 231 283 260 239 184 167 138 173 144 160
Total Debt		 15 15 15 15 16 15 21 21 21 0.44 0.53
Total Long-Term Debt		 15 15 15 15 15 15 20 14 9.30 0.00 0.00
Net Debt		 -241 -217 -198 -141 -139 -120 -114 -93 -129 -149 -168
Capital Expenditures (CapEx)		 0.44 0.13 0.00 0.02 0.01 0.00 0.00 0.01 0.27 0.13 0.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.90 -2.65 -13 11 -8.52 -2.84 -6.23 -10 -9.07 -18 0.05
Debt-free Net Working Capital (DFNWC)		 248 225 196 166 103 101 95 62 99 78 115
Net Working Capital (NWC)		 248 225 196 165 102 100 94 55 87 77 114
Net Nonoperating Expense (NNE)		 11 11 -70 -4.35 11 39 10 18 12 10 41
Net Nonoperating Obligations (NNO)		 -241 -217 -198 -141 -139 -120 -114 -93 -129 -149 -168
Total Depreciation and Amortization (D&A)		 0.15 0.17 0.17 0.20 0.18 0.18 0.21 0.41 0.37 0.25 0.23
Debt-free, Cash-free Net Working Capital to Revenue		 -704.81% -973.53% -3,840.00% 3,659.24% -3,074.01% -752.12% -1,882.78% -3,345.78% -487.06% -795.67% 1.59%
Debt-free Net Working Capital to Revenue		 91,844.44% 82,663.24% 58,546.27% 52,785.67% 37,087.00% 26,588.10% 28,606.65% 20,137.99% 5,320.99% 3,359.51% 3,799.01%
Net Working Capital to Revenue		 91,844.44% 82,663.24% 58,546.27% 52,698.09% 36,998.92% 26,524.87% 28,529.00% 17,913.64% 4,695.49% 3,340.58% 3,781.38%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.21) ($0.21) $0.28 ($0.11) ($0.17) ($0.36) ($0.16) ($0.24) ($0.15) ($0.14) ($0.28)
Adjusted Weighted Average Basic Shares Outstanding		 155.79M 155.79M 155.79M 158.83M 158.89M 160.39M 160.62M 160.16M 176.27M 196.56M 217.60M
Adjusted Diluted Earnings per Share		 ($0.21) ($0.21) $0.25 ($0.08) ($0.17) ($0.36) ($0.16) ($0.24) ($0.15) ($0.14) ($0.28)
Adjusted Weighted Average Diluted Shares Outstanding		 155.79M 155.79M 177.57M 158.83M 158.89M 160.39M 160.62M 160.16M 176.27M 196.56M 217.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 166.01M 166.01M 166.01M 166.03M 167.41M 167.80M 167.80M 198.31M 200.34M 214.34M 363.19M
Normalized Net Operating Profit after Tax (NOPAT)		 -23 -22 -27 -23 -17 -18 -16 -21 -14 -18 -20
Normalized NOPAT Margin		 -62,837.30% -12,967.09% -30,676.26% -130,515.00% 0.00% -6,597.18% -39,553.50% 0.00% -916.98% -2,460.51% -2,657.57%
Pre Tax Income Margin		 -89,610.81% -18,405.81% 50,398.85% -101,772.22% 0.00% -20,907.33% -66,157.50% 0.00% -1,691.90% -3,846.04% -8,139.79%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -52.75 -47.57 64.02 -26.59 -36.83 -80.47 -33.00 -40.36 -28.20 -19.05 0.00
NOPAT to Interest Expense		 -37.38 -33.90 -38.90 -34.05 -24.54 -25.66 -20.21 -22.26 -15.84 -11.19 0.00
EBIT Less CapEx to Interest Expense		 -53.46 -47.77 64.02 -26.61 -36.84 -80.47 -33.00 -40.37 -28.50 -19.13 0.00
NOPAT Less CapEx to Interest Expense		 -38.09 -34.09 -38.91 -34.07 -24.55 -25.66 -20.21 -22.27 -16.14 -11.27 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

ATAI Life Sciences (NASDAQ: ATAI) continues to look like a development-stage biotech with meaningful cash resources, but also sizable and persistent losses. The latest quarter shows modest revenue, heavy operating spending, and a large net loss, while the balance sheet still provides a substantial liquidity cushion.

  • Cash and investments remain sizable. At the end of Q3 2025, ATAI had about $30.4 million in cash and equivalents and $84.2 million in short-term investments, plus $53.9 million in long-term investments.
  • Liquidity improved versus the prior quarter. Total current assets rose to $130.7 million in Q3 from $102.7 million in Q2 2025, helped by a larger cash/investment position.
  • Net cash from investing activities was positive in Q2 2025 and quarter-to-quarter capital management remained active. The company has shown flexibility in moving funds between cash and investments to support operations.
  • Revenue is still very small. Q3 2025 revenue was only $749,000, up slightly from $719,000 in Q2 2025, but still immaterial relative to expenses.
  • Operating expenses remain high but were lower than earlier in 2025. Q3 2025 operating expenses were $29.2 million, versus $26.0 million in Q2 and $30.3 million in Q4 2024, reflecting a still-costly but somewhat variable spending profile.
  • Share count continues to rise. Weighted average basic shares increased to 217.6 million in Q3 2025 from 196.6 million in Q2, and from 176.3 million in Q1, indicating ongoing dilution.
  • Losses remain very large. ATAI posted a Q3 2025 net loss of $61.1 million, wider than the $27.7 million loss in Q2 2025 and the $26.5 million loss in Q1 2025.
  • Operating losses worsened sharply in Q3. Operating loss was $28.4 million, driven by roughly $29.2 million of operating expenses against just $749,000 of revenue.
  • Other income/expense was a major drag in Q3. The company recorded $32.7 million in net other expense, which pushed pre-tax loss to nearly $61.0 million.
  • Cash burn from operations remains significant. ATAI used $23.3 million of cash in operating activities in Q3 2025, after burning $14.1 million in Q2 and $17.8 million in Q1.

Looking at the broader trend, ATAI’s balance sheet is still much stronger than it was a year ago in terms of absolute liquid assets, but the company is also burning cash steadily to fund research and development. That means the stock’s long-term story is still highly dependent on clinical progress, financing execution, and whether revenue can eventually scale meaningfully.

One encouraging point is that the company still has a sizable asset base relative to current liabilities, and long-term debt is minimal in the latest quarter. The main risk for retail investors remains dilution and continued operating losses until one or more pipeline assets create a clearer commercial path.

07/17/26 12:06 AM ETAI Generated. May Contain Errors.

Atai Beckley Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Atai Beckley's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Atai Beckley's net income appears to be on a downward trend, with a most recent value of -$6.87 million in 2025, falling from $3.72 million in 2015. The previous period was -$4.95 million in 2024. See Atai Beckley's forecast for analyst expectations on what's next for the company.

Atai Beckley's total operating income in 2025 was -$9.17 million, based on the following breakdown:
  • Total Gross Profit: $18.63 million
  • Total Operating Expenses: $27.80 million

Over the last 10 years, Atai Beckley's total revenue changed from $56.44 million in 2015 to $38.34 million in 2025, a change of -32.1%.

Atai Beckley's total liabilities were at $53.81 million at the end of 2025, a 4.1% increase from 2024, and a 328.4% increase since 2015.

In the past 10 years, Atai Beckley's cash and equivalents has ranged from $5.00 million in 2024 to $38.73 million in 2015, and is currently $12.19 million as of their latest financial filing in 2025.

Over the last 10 years, Atai Beckley's book value per share changed from 1.32 in 2015 to 0.07 in 2025, a change of -94.6%.


Related Companies

Financial statements for NASDAQ:ATAI last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
What Saudi Arabia just did to the dollar changes everything
In June 2024, a 50-year arrangement tying Saudi oil to the U.S. dollar quietly expired. Garrett Goggin, CFA, C...
Golden Portfolio | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
AI investors should get ready for a BIG surprise
Wall Street insider Jason Bodner - who called Nvidia at $4.50 - says today's most popular AI stocks are about ...
Brownstone Research | Sponsoredtc pixel
Elon just confirmed my prediction
Elon Musk has officially confirmed a major new financial venture - and over 1 billion dollars is already flowi...
InvestorPlace | Sponsoredtc pixel